Stephen J. Schuster

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

March, 2025

Stephen J. Schuster

Dec 25, 2024, 03:00 | Insight

Mazyar Shadman: Venetoclax - based therapy after cBTKi in CLL led by Nilanjan Ghosh

Mazyar Shadman, Associate Professor of Medical Oncology at Fred Hutch Cancer Centre, shared on X…

Aug 12, 2024, 01:20 | Blog

Using CRISPR technology to enhance CAR-T cells

Patrick Hwu shared on X: "How do we make more effective CAR-T cells? The Marco Ruella…

Jul 25, 2024, 20:13 | Insight

Optimizing the Post-CAR T Monitoring Period

Al-Ola A Abdallah, Associate Professor and Plasma Cell Disorder Program Director at Division of HMCT/University…

All: 3 Posts: 1 - 100

'

Karen Knudsen has been appointed as the CEO of the Parker Institute for Cancer Immunotherapy

'

Highlights from ELCC 2025

'

FDA Approved Pluvicto (177Lu-PSMA-617) for Metastatic Castration-Resistant Prostate Cancer

'

Meet the New AACR Board of Directores for 2025-2028 Term

'

Do Artificial Sweeteners Cause Cancer? Myths and Facts

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023